Literature DB >> 35842560

The safety and feasibility of retrograde balloon aortic valvuloplasty using the INOUE-BALLOON with severe aortic stenosis.

Naoko Yuzawa-Tsukada1,2, Yusuke Kashiwagi3, Akira Nonoue4,3, Goki Uno4,3, Shinya Fujii4,3, Akimichi Murakami4, Kazuo Ogawa3, Makoto Kawai3, Makoto Muto4,3, Michihiro Yoshimura3, Takashi Miyamoto4.   

Abstract

In the transcatheter aortic valve implantation (TAVI) era, the indications for balloon aortic valvuloplasty (BAV) are increasing. Previously, the INOUE-BALLOON® (IB) was used only for antegrade BAV, but recently, it has also been used for retrograde BAV. However, the safety and feasibility of retrograde BAV using an IB are not fully understood. In this study, we investigated the safety and feasibility of retrograde BAV using an IB in elderly Japanese patients with severe aortic stenosis (AS). We compared 39 cases of retrograde BAV using an IB performed from June 2018 to September 2020 and 34 cases of antegrade BAV using an IB performed from August 2013 to May 2018. The total number of complications was lower in retrograde BAV than in antegrade BAV (p = 0.020). The procedure time was significantly shorter in retrograde BAV than in antegrade BAV (p < 0.001), and the maximum balloon size and number of balloon inflations were smaller in retrograde BAV than in antegrade BAV (p = 0.002 and p < 0.001, respectively). There was no significant difference in the degree of improvement in the aortic valve area or ejection fraction between retrograde and antegrade BAV. In conclusion, the present study showed the safety and feasibility of retrograde BAV using an IB in elderly Japanese patients with severe AS compared with antegrade BAV using an IB.
© 2022. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  INOUE BALLOON; Retrograde BAV; Retrograde PTAV; Severe aortic stenosis

Mesh:

Year:  2022        PMID: 35842560     DOI: 10.1007/s00380-022-02120-0

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   1.814


  4 in total

1.  Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it?

Authors:  Christian Witzke; Creighton W Don; Roberto J Cubeddu; Jesus Herrero-Garibi; Eugene Pomerantsev; Angel Caldera; David McCarty; Ignacio Inglessis; Igor F Palacios
Journal:  Catheter Cardiovasc Interv       Date:  2010-02-15       Impact factor: 2.692

2.  The Efficacy and Safety of Antegrade Inoue-Balloon Aortic Valvuloplasty to Treat Calcific Critical Aortic Stenosis.

Authors:  Yoshihito Sakata; Kenshun Matsubara; Seiji Tamiya; Yasufumi Hayama; Kazutane Usui
Journal:  J Invasive Cardiol       Date:  2015-08       Impact factor: 2.022

3.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Authors:  Catherine M Otto; Rick A Nishimura; Robert O Bonow; Blase A Carabello; John P Erwin; Federico Gentile; Hani Jneid; Eric V Krieger; Michael Mack; Christopher McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson; Christopher Toly
Journal:  Circulation       Date:  2020-12-17       Impact factor: 29.690

4.  Aortic balloon valvuloplasty as a bridge-to-decision in patients with aortic stenosis.

Authors:  Jacek Wacławski; Krzysztof Wilczek; Bartosz Hudzik; Damian Pres; Michał Hawranek; Krzysztof Milewski; Piotr Chodór; Michał Zembala; Mariusz Gąsior
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-06-26       Impact factor: 1.426

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.